Ikarian Capital, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Forte Biosciences, Inc. Common Stock, $0.001 par value (FBRX)

Filing Manager: Ikarian Capital, LLC
Reporting Manager: Ikarian Capital, LLC
Security: Forte Biosciences, Inc. Common Stock, $0.001 par value
Symbol: FBRX
Shares outstanding: 12,378,096 shares
Disclosed Ownership: 617,667 shares
Ownership: 4.99%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 16:20:41 UTC
Date of event: 30 Jun 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ikarian Capital, LLC	4.99%	617,667	0	617,667	/s/ Neil Shahrestani	Neil Shahrestani, Sole Manager
Neil Shahrestani	4.99%	617,667	0	617,667	/s/ Neil Shahrestani	Neil Shahrestani